Trial Outcomes & Findings for Feasibility and Preliminary Efficacy of an Opioid Stewardship Program in Hospitalized Patients With Chronic Pain (NCT NCT05370326)

NCT ID: NCT05370326

Last Updated: 2024-03-05

Results Overview

Feasibility of recruitment will be determined by a count of the number of participants screened for the study compared to number of eligible participants.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

52 participants

Primary outcome timeframe

approximately 3 months

Results posted on

2024-03-05

Participant Flow

Participant milestones

Participant milestones
Measure
Enhanced Opioid Stewardship Program
Enhanced opioid stewardship program, tailored to the needs of hospitalized patients with chronic pain with opioid dependence, incorporating real-time guidance from an addiction medicine and pain-trained physician/pharmacist team Enhanced Opioid Stewardship Program: The goal of the enhanced opioid stewardship intervention is to manage chronic pain while reducing risk of inappropriate/risky opioid use and preventing harms of opioid use.
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
Overall Study
STARTED
36
16
Overall Study
Complete Clinical Data
36
16
Overall Study
Complete Self Report Data
31
14
Overall Study
COMPLETED
36
16
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Feasibility and Preliminary Efficacy of an Opioid Stewardship Program in Hospitalized Patients With Chronic Pain

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Enhanced Opioid Stewardship Program
n=36 Participants
Enhanced opioid stewardship program, tailored to the needs of hospitalized patients with chronic pain with opioid dependence, incorporating real-time guidance from an addiction medicine and pain-trained physician/pharmacist team Enhanced Opioid Stewardship Program: The goal of the enhanced opioid stewardship intervention is to manage chronic pain while reducing risk of inappropriate/risky opioid use and preventing harms of opioid use.
Standard of Care
n=16 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
Total
n=52 Participants
Total of all reporting groups
Age, Continuous
55.1 years
STANDARD_DEVIATION 13.7 • n=5 Participants
52.3 years
STANDARD_DEVIATION 15.0 • n=7 Participants
53.7 years
STANDARD_DEVIATION 14.0 • n=5 Participants
Sex: Female, Male
Female
18 Participants
n=5 Participants
10 Participants
n=7 Participants
28 Participants
n=5 Participants
Sex: Female, Male
Male
18 Participants
n=5 Participants
6 Participants
n=7 Participants
24 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
n=5 Participants
6 Participants
n=7 Participants
11 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
31 Participants
n=5 Participants
10 Participants
n=7 Participants
41 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
15 Participants
n=5 Participants
4 Participants
n=7 Participants
19 Participants
n=5 Participants
Race (NIH/OMB)
White
20 Participants
n=5 Participants
9 Participants
n=7 Participants
29 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Region of Enrollment
United States
36 participants
n=5 Participants
16 participants
n=7 Participants
52 participants
n=5 Participants

PRIMARY outcome

Timeframe: approximately 3 months

Population: All participants that were screened for eligibility

Feasibility of recruitment will be determined by a count of the number of participants screened for the study compared to number of eligible participants.

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=510 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
Number of Participants Screened Compared to Number of Eligible Participants to Determine Feasibility of Recruitment
Eligible participants approached
97 Participants
Number of Participants Screened Compared to Number of Eligible Participants to Determine Feasibility of Recruitment
Ineligible participants due to Inclusion
62 Participants
Number of Participants Screened Compared to Number of Eligible Participants to Determine Feasibility of Recruitment
Ineligible participants due to Exclusion
351 Participants

PRIMARY outcome

Timeframe: approximately 3 months

Population: Total number of eligible participants.

Feasibility of recruitment will be determined by a count of the number of participants eligible for the study compared to number of enrolled participants.

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=97 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
Number of Eligible Participants Compared to Number of Enrolled Participants to Determine Feasibility of Recruitment
Declined to hear about study
22 Participants
Number of Eligible Participants Compared to Number of Enrolled Participants to Determine Feasibility of Recruitment
Agreed to hear about study: Consented
52 Participants
Number of Eligible Participants Compared to Number of Enrolled Participants to Determine Feasibility of Recruitment
Agreed to hear about study: Did not consent
23 Participants

PRIMARY outcome

Timeframe: approximately 3 months

Days to hospital day of enrollment in relation to admission and discharge dates

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
n=16 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
Days to Hospital Day of Enrollment
9.66 days
Standard Error 1.12
10.56 days
Standard Error 2.30

PRIMARY outcome

Timeframe: approximately 3 months

Population: Only participants in the intervention.

Number of participants in the intervention group who were able to receive the full enhanced opioid stewardship intervention to determine retention

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
Number of Participants in the Intervention Group Who Were Able to Receive the Full Enhanced Opioid Stewardship Intervention
36 Participants

PRIMARY outcome

Timeframe: approximately 3 months

Population: Only participants in the intervention.

Number of participants in the intervention group who were able to complete the peri-discharge evaluation to determine retention.

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
Number of Participants in Intervention Group Who Complete the Peri-discharge Evaluation.
Clinical outcomes provided
36 Participants
Number of Participants in Intervention Group Who Complete the Peri-discharge Evaluation.
Self reported outcomes provided
31 Participants

PRIMARY outcome

Timeframe: approximately 3 months

Population: Only participants in the control group.

Number of participants in the control group who were able to complete the peri-discharge evaluation to determine retention.

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=16 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
Number of Participants in Control Group Who Complete the Peri-discharge Evaluation.
Clinical outcomes provided
16 Participants
Number of Participants in Control Group Who Complete the Peri-discharge Evaluation.
Self-reported outcomes provided
14 Participants

SECONDARY outcome

Timeframe: approximately 4 months

Population: Only those in Enhanced Opioid Stewardship Program

A a count of guideline-based care elements considered to be "best practices" for opioid stewardship in the setting of chronic pain will be collected during hospitalizations. These include ordering of alternative pain relief medications (e.g., acetaminophen), ordering of a bowel regimen, ordering of medication to treat opioid use disorder, order of urine toxicology screen, ordering of ECG for patients prescribed methadone, avoidance of co-prescriptions of benzodiazepines, and other associate "best care" practices. These metrics will be abstracted from the medical record. The number is out of a possible 12 recommendations- 12 would be the most recommendations a participant could have received.

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
Number of Guideline-based Care Elements in Use Considered Guideline Concordant Care With Opioids for Pain During Hospitalization.
4.4 Physician guideline-concordant recommend
Interval 2.0 to 8.0

SECONDARY outcome

Timeframe: Baseline and 48 hours prior to discharge from hospital

Population: Participants with complete data

The Brief Pain Inventory measures the intensity of pain, along with the degree to which the pain interferes with the everyday functioning of life. Scores range from 0 (no pain) to 10 (severe pain).

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=30 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
n=14 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
Change in Pain Intensity Measured by the Brief Pain Inventory - Severity
-0.46 score on a scale
Standard Error 0.26
-0.23 score on a scale
Standard Error 0.59

SECONDARY outcome

Timeframe: Baseline and 48 hours prior to discharge from hospital

Population: Participants with complete data

The Brief Pain Inventory measures the intensity of pain, along with the degree to which the pain interferes with the everyday functioning of life. Scores range from 0 (no life interference) to 10 (complete interference).

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=30 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
n=14 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
Change in Pain Intensity Measured by the Brief Pain Inventory - Interference
-1.21 score on a scale
Standard Error 0.50
-0.62 score on a scale
Standard Error 0.64

SECONDARY outcome

Timeframe: Baseline and 48 hours prior to discharge from hospital

Population: Participants with complete data.

The Patient Health Questionnaire measures Change in depression. Scores range from 0 (no depression) to 27 (severe depression).

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=30 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
n=14 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
Change in Depression Measured by the Patient Health Questionnaire
-0.56 score on a scale
Standard Error 0.38
-0.35 score on a scale
Standard Error 0.43

SECONDARY outcome

Timeframe: 48 hours prior to discharge from hospital

Population: These data were not collected.

Patient satisfaction will be measured using a Likert scale with scores ranging from a scale of 1-5 (1 not satisfied, 5 very satisfied). These data were not collected as part of the completed study.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: up to 30 days post hospitalization

Population: All participants

The Number of participants with hospital re-admissions at 30 days after hospitalization. Outcome was updated upon results entry.

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
n=16 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
Count of Participants With Hospital Re-admissions at 30 Days After Hospitalization
Readmission in 30 days: Yes
14 Participants
4 Participants
Count of Participants With Hospital Re-admissions at 30 Days After Hospitalization
Readmission in 30 days: No
22 Participants
12 Participants

SECONDARY outcome

Timeframe: up to 30 days post hospitalization

Population: All participants

The count of participants with emergency department visits at 30 days after hospitalization. The outcome was updated when results were entered.

Outcome measures

Outcome measures
Measure
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
Standard of Care
n=16 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
Count of Participants With Emergency Department Visit(s) at 30 Days After Hospitalization
ED Visit within 30 Days: Yes
15 Participants
5 Participants
Count of Participants With Emergency Department Visit(s) at 30 Days After Hospitalization
ED Visit within 30 Days: No
21 Participants
11 Participants

Adverse Events

Enhanced Opioid Stewardship Program

Serious events: 1 serious events
Other events: 0 other events
Deaths: 1 deaths

Standard of Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Enhanced Opioid Stewardship Program
n=36 participants at risk
Enhanced opioid stewardship program, tailored to the needs of hospitalized patients with chronic pain with opioid dependence, incorporating real-time guidance from an addiction medicine and pain-trained physician/pharmacist team Enhanced Opioid Stewardship Program: The goal of the enhanced opioid stewardship intervention is to manage chronic pain while reducing risk of inappropriate/risky opioid use and preventing harms of opioid use.
Standard of Care
n=16 participants at risk
Participants received standard of care services without the enhanced opioid stewardship program.
Cardiac disorders
Cardiorespiratory arrest
2.8%
1/36 • Number of events 1 • Up to 4 months
0.00%
0/16 • Up to 4 months

Other adverse events

Adverse event data not reported

Additional Information

Melissa B. Weimer, DO, MCR, DFASAM

Yale School of Medicine

Phone: (203) 859-2962

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place